Company Lookup
عربي
Download Demo
 

Market News

This Month News

This Month News

send to a friend by email

Jerusalem Pharmaceutical earns a pretax profit of JD2.63 million in 2010

2011-02-20

Jerusalem Pharmaceutical disclosed the preliminary annual financial statements for the year 2010, which indicated pretax profit of JD 2.63 million compared to JD 1.65  million in 2009.

 To view Sahem’s report regarding the company’s financial results, click on the following link:

Sahem Fact Sheet 2010


 

2017-07-20
High liquidity level raises the market's trading volume this week

2017-07-18
PICO approves raising the paid-capital to $6 million

2017-07-18
TIC approves raising the paid-capital to $10.00 million

2017-07-13
Active Trading with the increase of semi-annual financial data anticipation

2017-07-12
LADAEN restructures itself and establishes a new company

2017-07-06
Al-Quds Index breaks through new psychological level and gains 2.99% in this week

 

 

 
Sahem Trading & Investments Company - PEX Member and licensed by PCMA
© All Rights Reserved 2013